Company

PROTIER Biotech Inc.

PROTIER Biotech develops targeted biopharmaceuticals, including therapies for cancer.

About

Founded in 2022 and based in Seoul, South Korea, PROTIER Biotech develops targeted therapeutics using its TPD and Molecular Glue platforms. It focuses on diseases including cancer and plans to advance drug candidates into preclinical development. In March 2026, it raised KRW 3.5 billion to support research and pipeline development.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in